A prime opportunity for pharma to raise its strategic game in ESG.
Jen Nixon
Advertisement
Articles by Jen Nixon
The pharma industry is beginning to perform better with environmental, social, and governance (ESG).
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Novartis Planning Layoffs for 550 Positions at Switzerland Facility
2
Novo Nordisk Submits Higher-Dose Wegovy Injectable for FDA Approval with Priority Voucher
3
Next-Gen CDMOs: Keeping Pace With Industry Change
4
Aidoc Submits Breakthrough-Designated Multi-Triage Device for FDA Approval
5
